chrion group english
TRANSCRIPT
-
8/3/2019 Chrion Group English
1/7
-
8/3/2019 Chrion Group English
2/7
Our mission
Globalizar las nuevas tendencias teraputic
Localizar segmentosensear a nuestros c
Our vision
To become a conduit for identifying and marketing the
latest therapies in new global markets.
To assist our clients in accessing the latest medical and
therapeutic trends so that they can be the first movers
in incorporating them in their portfolios.
To research and seek out high -value niche products in
each market and impart that knowledge to our clients,
assisting them to take full advantage of such
opportunities.
To remain at the cutting edge of new
developments in medical and therapeutic
trends.
To assist our clients in identifying and takingadvantage of those opportunities which are
most relevant for them given their
competencies.
-
8/3/2019 Chrion Group English
3/7
Our knowledge base extends back more than a
decade. Our current focus is to assist our clients in
marketing new medical therapies and technologies
in the Latin American market.
Weve facilitated access for our clients to enter key
markets which otherwise would have been
daunting.
Our group assists clients by identifying key
products that can provide them access to new and
growing markets. We stand with our clients each
step of the way.
Our group boasts a roster of more than 60 laboratories and
manufacturing firms, each a leader in its segment.
In oncology, we have positioned ourselves at the forefront of
medical innovation, sourcing and promoting key molecules
like bortezomib, azacitidine, i xabepilona and imanitib.
In hematology, we have been focusing on leading therapieslike tirofiban, prasugrel and fingolimod.
Chrions footprint can be found throughout the globe, having
worked in markets as diverse as India, Europe, Mauritius,
South Africa, Singapore, New Zealand, Australia, as well as
various Latin American markets.
-
8/3/2019 Chrion Group English
4/7
Our regulatory research team is expert in the registration process
involved in bringing a new product to a new market, adding great value
by expediting the administrative process.
We are well versed in and keep abreast of all registration proceduresand requirements of different markets (e.g., TGA in
Australia, ANVISA in
Brazil, MCC in
South Africa,
MHRA in the
United Kingdom, INVIMA in
Colombia, CECMED in Cuba), vastly reducing the anticipated delays in
securing the proper authorizations.
All manufacturing plants and laboratories are inspected by a team of
auditors, ensuring that each meets the rigorous standards set by ourgroup which ultimately translates to the best quality products for our
clients.
-
8/3/2019 Chrion Group English
5/7
Our base of operations is in Panama, the heart of Latin America, which
offers significant synergies across different markets.
Our experience in identifying emerging
medical and therapeutic trends in different
markets, as well as our focus on researchmeans that we know which products to focus
on in each segment.
We offer a sound cost/quality proposition
which assures our client a firm foothold in
growing segments that offer stellar growth
opportunities.
-
8/3/2019 Chrion Group English
6/7
We also work closely with a number of NGOs to assist
emerging economies by helping them source quality
products at a sound price.
Through our affiliate network, we are able to tap
inventories of generic medications, medical devices and
hospital products for the benefit of our NGO clients,
allowing us to provide these products in the shortest
possible delays.
Chrion has also assisted various governments
in Africa with their vaccination programs,
tuberculosis diagnosis and awareness
campaigns, sourcing and distribution of
products for the treatment of AIDS, as well
as offering quality primary care products.
-
8/3/2019 Chrion Group English
7/7
[email protected] Capital Plaza, Urbanizacin Costa del Este.19th Floor, Ciudad de Panam, Panam.
www.chriongroup.com